Acacia Pharma Group Plc
Acacia Pharma Group Plc
  • Home
  • Company
    • Overview
    • Strategy
    • Board
    • Management
  • Pipeline
    • Overview
    • Nausea & Vomiting
    • BARHEMSYS®
    • APD403
  • Partnering
  • Media
    • Press Releases
    • Events
  • Investors
    • Overview
    • Regulatory Announcements
    • Share Information
    • Share Price and Charts
    • Financial Reports and Presentations
    • Shareholder Meetings
    • Financial Calendar
    • Analysts
    • Corporate Governance
    • Warning for Shareholders
    • Subscribe for Updates
    • Initial Global Offering
  • Join Our Team
    • Current Openings
    • Our Cultural Hallmarks
    • US Employee Benefits
    • Staffing Agencies
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map
Acacia Pharma Group Plc
  • Home
  • Company
    • Overview
    • Strategy
    • Board
    • Management
  • Pipeline
    • Overview
    • Nausea & Vomiting
    • BARHEMSYS®
    • APD403
  • Partnering
  • Media
    • Press Releases
    • Events
  • Investors
    • Overview
    • Regulatory Announcements
    • Share Information
    • Share Price and Charts
    • Financial Reports and Presentations
    • Shareholder Meetings
    • Financial Calendar
    • Analysts
    • Corporate Governance
    • Warning for Shareholders
    • Subscribe for Updates
    • Initial Global Offering
  • Join Our Team
    • Current Openings
    • Our Cultural Hallmarks
    • US Employee Benefits
    • Staffing Agencies
  • Contact

Transforming medicine

Advancing care

Home > News > Archive: 2011

Press Releases

06 December 2011

Acacia Pharma Announces Positive Results From Phase IIa Cancer Cachexia Study

25 July 2011

Phase 2 Clinical Trial Initiated With APD515 For Xerostomia

31 March 2011

Acacia Pharma Closes $10 Million Investment Round

16 February 2011

Phase 2a Clinical Trial Initiated With APD421 For Nausea & Vomiting

07 February 2011

Phase 1 Clinical Trial Completed With APD515 For Xerostomia

06 January 2011

Acacia Pharma Starts Clinical Trial With APD515 For Xerostomia

06 January 2011

New Website Launched
  • 2019 (13)
  • 2018 (14)
  • 2017 (1)
  • 2016 (3)
  • 2015 (4)
  • 2014 (1)
  • 2013 (4)
  • 2012 (3)
  • 2011 (7)
  • 2010 (1)
  • 2009 (5)
  • 2008 (3)

© 2019 Acacia Pharma Group Plc
(Registered in England and Wales No: 09759376)
Registered office address: The Officers’ Mess, Royston Road, Duxford, Cambridge CB22 4QH, UK

Acacia Pharma Limited (Registered in England and Wales No: 05934843) and Acacia Pharma Inc (Incorporated under the laws of Delaware, No: 5799660) are members of the Acacia Pharma Group

  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map

Website by Instinctif Partners

The tradename BARHEMSYS® has received conditional approval by the US FDA and has replaced the previously used BAREMSIS®.

By continuing to use acaciapharma.com you will be agreeing to the website Terms & Conditions, the Privacy Policy, and the use of Cookies.